- Centers near me
- Gujarat
- Surat
- Nanpura
Metropolis Healthcare Ltd
- Yash lab
- No U12 & 13, Trade House
Nanpura
Surat - 395001 - Above Sainath Dhosa Centre
-
- Open until 09:00 PM
- Call Us Book Home Visit Directions
Social Timeline
We are pleased to announce the appointment of Dr. Abhay Bhave as the Medical Advisory Board Member for ‘Oncomet’. Dr. Bhave is a Fellow of the Royal College of Pathologists at WestMead Hospital, Sydney and has received advanced training in Bone Marrow Transplant at Oman. He practices as Consultant Hematologist at Lilavati Hospital & Research Center, Empire Hematology Oncology Day Care Center and Global Hospital. #Oncomet #WelcomePost #MetropolisLabs #HealthCare #Oncomet #WelcomePost #MetropolisLabs #HealthCare
According to an Indian Council of Medical Research (ICMR) study, one in nine Indians are likely to develop cancer in their lifetime. It is not women who are being affected with cancer, men are also equally at risk with the cancer prevalence continually showing an upward trend among them. Here’s an article authored by Dr Shaikhali Barodawala, Scientific and Business Head, Integrated Oncopathology, Consultant and Head, Anatomic Pathology, Global Reference Laboratory, Metropolis Labs, in which he briefly highlights on the most common cancer symptoms for men in order to seek timely care and detection. #MetropolisLabs #MetropolisScientificExpert #Healthcare #Oncomet #SuperSpeciality #CancerDiagnosis #Oncology #DiagnosticLeaderhttps://health.economictimes.indiatimes.com/news/industry/minimizing-the-fear-of-unknown-mens-common-cancer-symptoms/98036165 #MetropolisLabs #MetropolisScientificExpert #Healthcare #Oncomet #SuperSpeciality #CancerDiagnosis #Oncology #DiagnosticLeader
We are pleased to onboard Dr. Radheshyam Naik on the Medical Advisory Board for ‘Oncomet’. Dr. Naik has received advanced training in autologous transplantation, palliative cancer care, intra-arterial chemotherapy, advanced nutrition, infections in immunocompromised and clinical trial statistics. He has successfully established special BMT & Hemat-Onco unit and founded Translational Medicine & Preventive Oncology departments at HCG. He is Consultant Medical Oncologist & Head of Clinical Research Trials at HCG Bangalore. #Oncomet #WelcomePost #MetropolisLabs #HealthCare #Oncomet #WelcomePost #MetropolisLabs #HealthCare
What is Bone Marrow Transplant? How it is beneficial to treat various diseases and different types of cancers? Here's an in-depth article contributed by Dr. Sanjay Gohil, Head of Hematology & Transplant Immunology, Metropolis Labs on the significance of Bone Marrow Transplantation in the treatment of cancer and several more diseases. Courtesy: The Financial Express #worldcancerday2023 #MetropolisLabs #Oncomet #Oncology #ScientificExpert #Healthcare #Diagnosis #hematology #Immunologyhttps://www.financialexpress.com/healthcare/wellness/bone-marrow-transplant-way-to-cure/2970915/ #worldcancerday2023 #MetropolisLabs #Oncomet #Oncology #ScientificExpert #Healthcare #Diagnosis #hematology #Immunology
#DiagnosticOncology has come a long way courtesy of technological advancement, precision oncology, and companion diagnostics culminating into optimal patient care. This #worldcancerday2023 , Dr Kirti Chadha, Chief Scientific Officer, Metropolis Labs joins other leading Oncology specialists to share her views with The Times of India on the advancements in diagnosis and treatment of cancer. #MolecularOncology #MetropolisScientificExpert #Cancer #Diagnosis #Oncomet #Research #Innovation #ScientificExcellence #Healthcare #MetropolisLab #DiagnosticOncology #worldcancerday2023 #MolecularOncology #MetropolisScientificExpert #Cancer #Diagnosis #Oncomet #Research #Innovation #ScientificExcellence #Healthcare #MetropolisLab
Cancer is one of the leading causes of death worldwide. In India alone, nearly 1.1 million new cases of cancer are reported annually. This #NationalCancerAwarenessDay, Metropolis Labs Senior Oncopathologist and Chief Scientific Officer, Dr Kirti Chadha speaks to Life and More Plus on the importance of screening and briefly elaborates on the advancements in cancer detection and treatment. Early detection is the key to prevention! So this #NationalCancerAwarenessDay, take a vow to get yourself screened regularly. You can start by booking your cancer screening test at Metropolis just visit - www.metropolisindia.com or call 9982-782-555. #MetropolisLabs #MetropolisHealthcare #Oncomet #Oncology #Cancer #Oncologist #Cancerawareness #CancerDiagnosis #FightCancer #healthcarehttps://www.youtube.com/watch?v=k62WlOD0nTg&t=12s #NationalCancerAwarenessDay #MetropolisLabs #MetropolisHealthcare #Oncomet #Oncology #Cancer #Oncologist #Cancerawareness #CancerDiagnosis #FightCancer #healthcare
Cancer burden in India is on an exponential rise. Early and accurate diagnosis is the key when it comes to arresting this disease. @Dr. Kirti Chadha takes us through the various screening programs, modalities, and parameters that should be taken into consideration during a cancer diagnosis to ensure an effective treatment for the patient. #MetropolisLabs #MetropolisHealthcare #Oncomet #Oncology # Cancer #Oncologist #Cancerawareness #CancerDiagnosis #FightCancer #MetropolisLabs #MetropolisHealthcare #Oncomet #Oncology #Oncologist #Cancerawareness #CancerDiagnosis #FightCancer
Check out this insightful interview of Dr Kirti Chadha, Chief Scientific Officer, Metropolis Labs, as she speaks to Financial Express (India) on the significance of ‘Noninvasive prenatal testing (NIPT)’ which is done to determine the risk that the fetus will be born with certain genetic abnormalities. In this article, she highlights the importance of such tests, scope of #genomics in India, #geneticabnormalities, among others. #MolecularGenomics #MetropolisInnovationCell #NextGenNIPT #NextGenBRCA #MolecularOncology #Genomexpert #Gynecexpert #Oncomet #genomics #geneticabnormalities #MolecularGenomics #MetropolisInnovationCell #NextGenNIPT #NextGenBRCA #MolecularOncology #Genomexpert #Gynecexpert #Oncomet
#BreastCancer and #OvarianCancer are the most common forms of cancer in women and constitute a major cause of cancer related mortality in women. Around 10-15% of breast cancers are attributed to mutations or alterations in #BReastCAncerGene (BRCA ½) genes, causing 40-50% of #hereditarybreastcancers. Experts suggest that the early risk detection of breast cancer through genetic testing can help in better management. In this article covered in #Onlymyhealth, Dr. Monisha Banerjee, Senior Consultant, Molecular Genomics and Genetic Counselling, Metropolis Healthcare Limited speaks on the significance of #Genetictesting, Pre & Post Counselling for the early detection of Breast Cancer risk. Want to know more about the Breast Cancer Gene Test available at Metropolis, write to our experts on medconnect@metropolisindia.com #Research #BRCA #Healthcare #Cancerscreening #HBOC #genomics #molecularoncology #metropolisinnovationcell #innovation #oncomethttps://www.onlymyhealth.com/genetic-counseling-breast-cancer-risk-1656941880 #BreastCancer #OvarianCancer #BReastCAncerGene #hereditarybreastcancers #Onlymyhealth #Genetictesting #Research #BRCA #Healthcare #Cancerscreening #HBOC #genomics #molecularoncology #metropolisinnovationcell #innovation #oncomet